High incidence of GalNAc disialosyl lactotetraosylceramide in metastatic renal cell carcinoma

Anticancer Research

Volumn 27, Issue 6 C, 2007, Pages 4345-4350

  Maruyama, Ryo ^a   Saito, Seiichi ^b   Bilim, Vladimir ^c   Hara, Noboru ^a   Itoi, Toshiyuki ^a   Yamana, Kazutoshi ^a   Nishiyama, Tsutomu ^a   Arai, Yoichi ^b   Takahashi, Kota ^a   Tomita, Yoshihiko ^c  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

Glycosphingolipids; Metastasis; Renal cell carcinoma

Indexed keywords

CERAMIDE DERIVATIVE; GALNAC DISIALOSYL LACTOTETRAOSYLCERAMIDE; GLYCOSPHINGOLIPIDS MONOSIALOSYL GLOBOPENTAOSYLCERAMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; GLYCOSPHINGOLIPIDS; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; KAPLAN-MEIERS ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 37549069283     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sandock DS, Seftel AD and Resnick MI: A new protocol for the follow up of renal cell carcinoma based on pathological stage. J Urol 154: 28-31, 1995.
2. Rabinovitch RA, Zelefsky MJ, Gaynor JJ and Fuks Z: Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol 12: 206-212, 1994.
3. Lam JS, Shvarts O, Leppert JT Pantuck AJ, Figlin RA and Belldegrun AS: Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 174: 466-472, 2005.
4. Mejean A, Oudard S and Thiounn N: Prognostic factors of renal cell carcinoma. J Urol 169: 821-827, 2003.
5. Zhou M and Rubin MA: Molecular markers for renal cell carcinoma: impact on diagnosis and treatment. Semin Urol Oncol 19: 80-87, 2001.
6. Hakomori S: Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 265: 18713-18716, 1990.
7. Hakomori S: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56: 5309-5318, 1996.
8. Nakamori S, Kameyama M, Imaoka S Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Iwanaga T, Matsushita Y and Irimura T: Increased expression of sialyl Lewis x antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53: 3632-3637, 1993.
9. Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S and Kim YS: A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66: 1960-1966, 1990.
10. Miyake M, Taki T, Hitomi S and Hakomori S: Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med 327: 14-18, 1992.
11. Lee JS, Ro JY, Sahin AA, Hong WK, Brown BW, Mountain CF and Hittelman WN: Expression of blood-group antigen A - a favorable prognostic factor in non-small cell lung cancer. N Engl J Med 324: 1084-1090, 1991.
12. Fukushi Y, Ohtani H and Orikasa S: Expression of lacto series type 2 antigens in human renal cell carcinoma and its clinical significance. J Natl Cancer Inst 81: 352-358, 1989.
13. Saito S, Orikasa S, Ohyama C, Satoh M and Fukushi Y: Changes in glycolipids in human renal-cell carcinoma and their clinical significance. Int J Cancer 49: 329-334, 1991.
14. Saito S, Levery SB, Salyan ME, Goldberg RI and Hakomori S: Common tetrasaccharide epitope NeuAc alpha 2 - >3Gal beta 1 - >3(Neu-Ac alpha 2 - >6)GalNAc, presented by different carrier glycosylceramides or O-linked peptides, is recognized by different antibodies and ligands having distinct specificities. J Biol Chem 269: 5644-5652, 1994.
15. Ito A, Levery SB, Saito S, Satoh M and Hakomori S: A novel ganglioside isolated from renal cell carcinoma. J Biol Chem 276: 16695-16703, 2001.
16. Saito S, Orikasa S, Satoh M, Ohyama C, Ito A and Takahashi T: Expression of globo-series gangliosides in human renal cell carcinoma. Jpn J Cancer Res 88: 652-659, 1997.
17. TNM Classification of Malignant Tumours, 6th Edition. Sobin LH, Wittekind Ch (eds.), Wiley, 2005.
18. Tomita Y, Watanabe H, Kobayashi H, Nishiyama T, Tsuji S, Imai K, Abo T, Fujiwara M and Sato S: Expression of intercellular adhesion molecule-1 on transitional cell cancer. Possible significance in immunity against tumor cells. Am J Pathol 143: 191-198, 1993.
19. Satoh M, Handa K, Saito S, Tokuyama S, Ito A, Miyao N, Orikasa S and Hakomori S: Disialosyl galactosylgloboside as an adhesion molecule expressed on renal cell carcinoma and its relationship to metastatic potential. Cancer Res 56: 1932-1938, 1996.
20. Satoh M, Nejad FM, Ohtani H, Ito A, Ohyama C, Saito S, Orikasa S and Hakomori S: Association of renal cell carcinoma antigen, disialylgalactosylgloboside, with c-Src and Rho A in clustered domains at the surface membrane. Int J Oncol 16: 529-536, 2000.
21. Ito A, Handa K, Withers DA, Satoh M and Hakomori S: Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression. FEBS Lett 504: 82-86, 2001.
22. Aoki H, Satoh M, Mitsuzuka K, Ito A, Saito S, Funato T, Endoh M, Takahashi T and Arai Y: Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase. FEBS Lett 567: 203-208, 2004.